IGF1R and melanoma: Our results indicate that IGF-1R downregulation offers an approach to increase the sensitivity of melanoma cells to MAPK inhibition, while highlighting that a good understanding of the molecular mechanisms could provide greater specificity and precision required for multi-hit personalized therapy (89, 90).